Month: April 2021

Seems like I got a lot of company when I got my vaccination – but only after a lot of hoohah. In our informal poll, almost half – 48 percent – of the nearly 300 respondents reported hours, days and even weeks of stress-filled effort before finally landing a spot somewhere.  One respondent in the
0 Comments
ClassyLady Glass Nail Files Crystal Nail File ClassyLady Beauty Be honest for a second, and think how much have you thought about your nail file. If you’re, well… like us, then the answer would probably be “not much.” Usually stashed in your purse, cabinet, or somewhere in your room it is easy to forget about
0 Comments
A study using data from Veterans Health Administration (VHA) electronic medical records shows a significant association between posttraumatic stress disorder (PTSD) among female veterans and an increased risk for incident ischemic heart disease (IHD). The increased risk for IHD was highest among women younger than 40 with PTSD, and among racial and ethnic minorities. “These
0 Comments
FDA Approves Nextstellis (drospirenone and estetrol) Oral Contraceptive for Birth Control 15 April 2021, Adelaide, Australia and Liege, Belgium: Mayne Pharma Group Limited (ASX: MYX) and Mithra Pharmaceuticals, SA (Euronext Brussels: MITRA) are very pleased to announce that the US Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for the novel
0 Comments
President Joe Biden puts his hand on a man’s shoulder during a visit to a coronavirus disease (COVID-19) vaccination site at Virginia Theological Seminary in Alexandria, Virginia, U.S., April 6, 2021. Kevin Lemarque | Reuters The Biden administration is preparing for the potential need of Covid-19 vaccine booster shots, though nothing is certain, a top
0 Comments
In focused attempts to bring an end to the deadly spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of the ongoing coronavirus disease 2019 (COVID-19) pandemic, two new mRNA vaccines were rolled out after receiving emergency use authorization (EUA) by the US Food and Drugs Administration (FDA). The mRNA vaccines Both
0 Comments
A year ago, the COVID-19 pandemic altered our world in myriad ways. We sheltered, socially distanced, masked in public. Due to safety and capacity concerns, health systems and providers scaled back non-emergency care, including canceling non-urgent surgeries. While this cautious approach was necessary early in the pandemic, it limited health systems’ and providers’ ability to
0 Comments
Overuse of alcohol among older adults is a mostly hidden story – for instance, National Drug and Alcohol Awareness Week (March 22-28 in 2021) is aimed at teens.  However, research suggests that one third of older drinkers develop the dependency later in life and that was before Covid-related stress and isolation.   How much drinking is
0 Comments
The US Food and Drug Administration has declared Medtronic’s recent recall of batteries, power, and data link cables and other peripheral equipment for its Heartware Ventricular Assist Device (HVAD) System as class I, the most serious category of safety alert, agency announced today. The recall, which the company announced to affected healthcare providers and patients
0 Comments
Happiful has always loved and admired the work of The Body Shop, but their campaign to improve self-love globally has inspired us to take action – and we encourage you to do the same… Each and every one of us will experience moments of self doubt and less-than positive thoughts about our abilities or the
0 Comments
Digital expert Harvey Morton shares his experience of burnout and tips for helping yourself out of it 2020 has had a significant impact on people’s mental health. Likely, we won’t see the full effects for a while. The positive from this difficult situation is that people are happier than ever to openly discuss challenges with
0 Comments
Working alongside mental health campaigner Jonny Benjamin, Britt Pflüger has curated a beautiful and inspiring collection of 101 stories of hope, but it’s the life experience of her rescue dog, a 16-year-old staffy called Matilda, that’s made the most impact upon her… If 2021 had a guiding word or theme, I believe it would be
0 Comments
So many of us are struggling with the thought of getting out and about as lockdown restrictions lift. Maybe the answer is SLOSO – a purposefully slow return to socialising? There was FOMO (fear of missing out), then there was JOMO (joy of missing out) and now as we work our way through the latest
0 Comments
PRINCETON, N.J., April 7, 2021 /PRNewswire/ – Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that the U.S. Food and Drug Administration (FDA) has conditionally accepted HyBryte™ as the proposed brand name for SGX301 (synthetic hypericin),
0 Comments
April 7, 2021 - The New England Journal of Medicine (NEJM) today published the final results of Part A of the pivotal Phase 3 CARDINAL open label, single-arm study evaluating the safety and efficacy of sutimlimab for 26 weeks in people with primary cold agglutinin disease (CAD). Sutimlimab, a first-in-class investigational C1s inhibitor, met the primary and secondary
0 Comments
TARRYTOWN, N.Y., April 9, 2021 /PRNewswire/ – Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced today that newly updated National Institutes of Health (NIH) COVID-19 Treatment Guidelines strongly recommend that REGEN-COV™ (casirivimab with imdevimab) be used in non-hospitalized COVID-19 patients (“outpatients”) at high risk of clinical progression. The Category ‘AIIa’ is a ‘strong’ rating based on results of randomized trials. The recommendation from the NIH COVID-19 Treatments
0 Comments
TARRYTOWN, N.Y., April 12, 2021 /PRNewswire/ –  REGEN-COV rapidly protected household contacts from exposure to SARS-CoV-2 at home, with 72% protection against symptomatic infections in the first week, and 93% in subsequent weeks Among individuals who developed symptomatic infections, REGEN-COV recipients cleared the virus faster and had much shorter symptom duration Regeneron will share data with U.S. FDA and
0 Comments
SERENE is a Phase 3 single-arm, open-label study evaluating the contraceptive efficacy of investigational relugolix combination tablet in sexually active, healthy women ages 18-35 years Contraceptive potential of relugolix combination tablet supported by prior Phase 1 study that demonstrated 100% ovulation inhibition Data would support a potential indication of pregnancy prevention for women treated with
0 Comments